4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-23-000282
Options or other derivatives
- PRINCIPAL ACCOUNTING OFFICER acquired 24,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| English Edward C PRINCIPAL ACCOUNTING OFFICER | 2023-01-01 | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | D | ||
Loading xslF345X03/form4-01042023_090144.xml…